.Merck beats profits desires, rears sales outlook on powerful need for top medications like Keytruda CNBCMerck & Co. (MRK United States) Defeats Profit Forecasts as Keytruda Sales Rise BloombergMerck Sell: Pharma Titan Posts Solid Results, However Overview Falls Short Entrepreneur's Organization DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck beats revenue as well as purchases assumptions among Keytruda strong point, yet supplies mixed full-year expectation MarketWatch.